CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in CymaBay Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 118
- +19 vs. Q3 2022
- Shares held
- 65.3M
- +4.64M (+7.7%) vs. Q3 2022
- Total value
- $404.2M
- +$192.1M (+90.5%) vs. Q3 2022
- New holders
- 26
- 30 more added
- Sold out
- 7
- 29 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $21.1K |
| Q4 2023 | 200 | $2.71B |
| Q3 2023 | 189 | $1.61B |
| Q2 2023 | 151 | $1.02B |
| Q1 2023 | 140 | $774.9M |
| Q4 2022 | 118 | $404.2M |
| Q3 2022 | 100 | $217.9M |
| Q2 2022 | 106 | $185.9M |
| Q1 2022 | 118 | $202.8M |
| Q4 2021 | 113 | $215.7M |
| Q3 2021 | 114 | $169.3M |
| Q2 2021 | 113 | $227.4M |
| Q1 2021 | 130 | $251.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding CymaBay Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Belvedere Trading LLC | 4,695 | $29.4K | 0.02% | +4,695 | New |
| IFP Advisors, Inc | 1,650 | $21.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,992 | $19.0K | 0.00% | −3,331−52.7% | Reduced |
| Tower Research Capital LLC (TRC) | 2,057 | $13.0K | 0.00% | −4,470−68.5% | Reduced |
| Truvestments Capital LLC | 1,391 | $8.72K | 0.00% | −96−6.5% | Reduced |
| EverSource Wealth Advisors, LLC | 1,313 | $8.23K | 0.00% | −389−22.9% | Reduced |
| Global Retirement Partners, LLC | 1,200 | $7.52K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 1,150 | $7.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 860 | $5.39K | 0.00% | +67+8.4% | Added |
| Wells Fargo & Company | 537 | $3.37K | 0.00% | −162−23.2% | Reduced |
| BNP Paribas Arbitrage, SA | 521 | $3.27K | 0.00% | +520+52,000.0% | Added |
| Steward Partners Investment Advisory, LLC | 500 | $3.13K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 341 | $2.00K | 0.00% | +189+124.3% | Added |
| Quadrant Capital Group LLC | 236 | $1.48K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 116 | $727 | 0.00% | +116 | New |
| Activest Wealth Management | 69 | $433 | 0.00% | 00.0% | Unchanged |
| Macroview Investment Management LLC | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Glassman Wealth Services | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −596,300−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −18,932−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,800−100.0% | Sold out |
| Bank of Nova Scotia | 0 | $0 | 0.00% | −14,286−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,094−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −288−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Foresite Capital Management III, LLC | – | – | – | – | Not filed |